| 2000). ³UK and France still at 'war' over BSE.² Australian Veterinary Journal. 78(2): 130. (2000). ³The BSE inquiry: chairman's closing statement.² Veterinary Record. 146(1): 2-3. (2000). ³Study links BSE and deadly human brain disease.² Journal Of The American Veterinary Medical Association. 216(4): 473. (2000). ³CJD and the spongiform encephalopathies.² British Journal Of Ophthalmology. 84(4): 346. (2000). ³BSE still a big problem - EU had 3000 cases in 1999.² Australian Veterinary Journal. 78(4): 230. (2000). ³Global infection - It's official: even in countries that deny it, some cattle are likely to be harbouring BSE.² New Scientist. Jun 166(2242): 4. (2000). ³BSE confirmed in a cow born after August 1, 1996.² Veterinary Record. Jul 147(2): 30. (2000). ³BSE: new guidelines from MAFF.² Veterinary Record. Jun 146(26): 743-744. Aguzzi, A. (2000). ³Prion diseases, blood and the immune system: concerns and reality.² Haematologica . 85(1): 3-10. Aldhous, P. (2000). ³CJD survey offers Britain a glimmer of hope.² Nature . 405(6782): 7. Allroggen, H., G. Dennis, et al. (2000). ³New variant Creutzfeldt-Jakob disease: three case reports from Leicestershire.² Journal Of Neurology Neurosurgery And Psychiatry. 68(3): 375-378. Alperovich, A. (2000). ³Codon 129 prion protein genotype and sporadic Creutzfeld-Jakob disease (vol 353, pg 1673, 1999).² Lancet . 355(9197): 72. Alperovitch, A. (2000). ³Variant CJD: finding a needle in a haystack?² Hospital Medicine. 61(2): 145. Alter, M. (2000). ³How is Creutzfeldt-Jakob disease acquired?² Neuroepidemiology . 19(2): 55-61. Altman, M., P. Lee, et al. (2000). ³Conformational behavior of ionic self-complementary peptides.² Protein Science. Jun 9(6): 1095-1105. Andrews, N. J., C. P. Farrington, et al. (2000). ³Incidence of variant Creutzfeldt-Jakob disease in the UK.² Lancet . 356(9228): 481-482. Armstrong, R. A., N. J. Cairns, et al. (2000). ³The spatial pattern of the vacuolation in patients with sporadic Creutzfeldt-Jakob disease.² Neuroscience Letters. 281(2-3): 187-190. Armstrong, R. A. (2000). ³Analysis of spatial patterns in histological sections of brain tissue using a method based on regression.² Journal Of Neuroscience Methods. 95(1): 39-45. Arrigo, A. P. (2000). ³sHsp as novel regulators of programmed cell death and tumorigenicity.² Pathologie Biologie. 48(3): 280-288. Atlan, H. (1999). ³Epigenesis and self-organization: new perspectives in Biology and Medicine.² Bulletin De L Academie Nationale De Medecine 183(7): 1421-1437. Barclay, G. R., R. Munks, et al. (1999). ³Variant Creutzfeldt-Jakob disease is not related to underlying IgA deficiency.² Transfusion Medicine 9(4): 383-384. Baron, T. G. M., J. Y. Madec, et al. (2000). ³Comparison of French natural scrapie isolates with bovine spongiform encephalopathy and experimental scrapie infected sheep.² Neuroscience Letters. 284(3): 175-178. Baskakov, I. V., C. Aagaard, et al. (2000). ³Self-assembly of recombinant prion protein of 106 residues.² Biochemistry . 39(10): 2792-2804. Baumann, M. H., J. Kallijarvi, et al. (2000). ³Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides.² Biochemical Journal. Jul 1: 77-84. Beck, J. A., S. Lloyd, et al. (2000). ³Genealogies of mouse inbred strains.² Nature Genetics. 24(1): 23-25. Beebe, D. W., G. N. Holmbeck, et al. (1999). ³Normative and psychometric data on the body image assessment-revised.² Journal Of Personality Assessment. 73(3): 374-394. Beekes, M. and P. A. McBride (2000). ³Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie.² Neuroscience Letters. 278(3): 181-184. Benvenga, S., A. Campenni, et al. (1999). ³Internal repeats of prion protein and A beta PP, and reciprocal similarity with the amyloid-related proteins.² Amyloid International Journal Of Experimental And Clinical Investigation. 6(4): 250-255. Berger, D., M. Filippov, et al. (1999). ³Experimental determination of energy resolution and transmission characteristics of an electrostatic toroidal spectrometer adapted to a standard scanning electron microscope.² Journal Of Electron Spectroscopy And Related Phenomena. 105(2-3): 119-127. Beringue, V., M. Demoy, et al. (2000). ³Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis.² Journal Of Pathology. 190(4): 495-502. Bidou, L., G. Stahl, et al. (2000). ³Nonsense-mediated decay mutants do not affect programmed-1 frameshifting.² Rna A Publication Of The Rna Society. Jul 6(7): 952-961. Birchard, K. (2000). ³BSE-testing time for European cattle.² Lancet . 355(9211): 1252. Blanquet Grossard, F., V. Sazdovitch, et al. (2000). ³Prion protein is not detectable in dental pulp from patients with Creutzfeldt-Jakob disease.² Journal Of Dental Research. 79(2): 700. Bleich, S., S. Kropp, et al. (2000). ³Creutzfeldt-Jakob disease and oxidative stress.² Acta Neurologica Scandinavica. 101(5): 332-334. Bohr, H. (2000). ³The intrinsic dynamics of proteins and the prion disease.² Mathematical And Computer Modelling. 31(4-5): 1-9. Bosque, P. J. and S. B. Prusiner (2000). ³Cultured cell sublines highly susceptible to prion infection.² Journal Of Virology. 74(9): 4377-4386. Brandner, S., M. A. Klein, et al. (2000). ³Mechanisms of neuroinvasion by prions: molecular principles and present status of research.² Schweizerische Medizinische Wochenschrift. 130(12): 435-442. Brown, W. M. and L. G. Skoglund (1999). ³High plains disease: virus, prion or extra-terrestrial? A review of a new disease.² Zeitschrift Fur Pflanzenkrankheiten Und Pflanzenschutz Journal Of Plant Diseases And Protection. 106(6): 660-663. Brown, K. L., K. Stewart, et al. (1999). ³Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells.² Nature Medicine. 5(11): 1308-1312. Brown, D. R., B. S. Wong, et al. (2000). ³Normal prion protein has an activity like that of superoxide dismutase (vol 344, pg 1, 1999).² Biochemical Journal. 3: 767. Brown, D. R. (2000). ³Prion protein peptides: Optimal toxicity and peptide blockade of toxicity.² Molecular And Cellular Neuroscience. 15(1): 66-78. Brown, D. R., F. Hafiz, et al. (2000). ³Consequences of manganese replacement of copper for prion protein function and proteinase resistance.² Embo Journal. 19(6): 1180-1186. Brown, P., E. H. Rau, et al. (2000). ³New studies on the heat resistance of hamster-adapted scrapie agent: Threshold survival after ashing at 600 degrees C suggests an inorganic template of replication.² Proceedings Of The National Academy Of Sciences Of The United States Of America. 97(7): 3418-3421. Brown, D. R., N. K. Iordanova, et al. (2000). ³Functional and structural differences between the prion protein from two alleles prnp(a) and prnp(b) of mouse.² European Journal Of Biochemistry. 267(8): 2452-2459. Brown, K. L., D. L. Ritchie, et al. (2000). ³Detection of PrP in extraneural tissues.² Microscopy Research And Technique. Jul 50(1): 40-45. Bruce, M. E. (2000). ³'New variant' Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.² Nature Medicine. 6(3): 258-259. Bryce, E. A., K. Dorovoni Zis, et al. (2000). ³Creutzfeldt-Jakob disease: Management of accidental contamination of neurosurgical instruments, pathology equipment, and solutions.² Infection Control And Hospital Epidemiology. 21(4): 247-248. Bugiani, O., G. Giaccone, et al. (2000). ³Neuropathology of Gerstmann-Straussler-Scheinker disease.² Microscopy Research And Technique. Jul 50(1): 10-15. Calzolai, L., D. A. Lysek, et al. (2000). ³NMR structures of three single-residue variants of the human prion protein.² Proceedings Of The National Academy Of Sciences Of The United States Of America. Jul 97(15): 8340-8345. Capellari, S., S. I. A. Zaidi, et al. (2000). ³Prion protein glycosylation is sensitive to redox change (vol 274, pg 34846, 1999).² Journal Of Biological Chemistry. 275(15): 11538. Casanova, B., M. de Entrambasaguas, et al. (1996). ³Lithium-induced Creutzfeldt-Jakob Syndrome.² Clinical Neuropharmacology. 1996 ; Vol 19(4): 356-359. Caselli, R. J. (2000). ³Focal and asymmetric cortical degenerative syndromes.² Corticobasal Degeneration And Related Disorders 82: 35-51. Caskie, P., J. Davis, et al. (1999). ³The economic impact of BSE: a regional perspective.² Applied Economics. 31(12): 1623-1630. Caughey, B. (2000). ³Transmissible spongiform encephalopathies, amyloidoses and yeast prions: Common threads?² Nature Medicine. Jul 6(7): 751-754. Chapman, J., L. Cervenakova, et al. (1998). ³APOE in non-Alzheimer amyloidoses: Transmissible spongiform encephalopathies.² Neurology. 1998 ; Vol 51(2): 548-553. Chernoff, Y. O., A. P. Galkin, et al. (2000). ³Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein.² Molecular Microbiology. 35(4): 865-876. Chiesa, R. and D. A. Harris (2000). ³Nerve growth factor-induced differentiation does not alter the biochemical properties of a mutant prion protein expressed in PC12 cells.² Journal Of Neurochemistry. Jul 75(1): 72-80. Clive, C. and S. J. Haswell (2000). ³Functional and structural differences between the prion protein from two alleles prnp(a) and prnp(b) of mouse. (vol 267, pg 2452, 2000).² European Journal Of Biochemistry. Jun 267(12): 3915. Cochereau, I. (1999). ³Disinfection of non invasive medical devices against prions.² Journal Francais D Ophtalmologie. 22(10): 1084-1089. Cockcroft, P. D. (2000). ³Clinical sign profile likelihood ratios for bovine spongiform encephalopathy suspects.² Research In Veterinary Science. Jun 68(3): 285-290. Coghlan, A. (2000). ³Reservoir sheep - Did BSE start in sheep, and could it still be lurking there?² New Scientist. Jul 167(2249): 20. Cohen, F. E. (2000). ³Prions, peptides and protein misfolding.² Molecular Medicine Today. Jul 6(7): 292-293. Cohn, D. A., D. S. Crimmins, et al. (2000). ³Creutzfeldt-Jakob disease: the need for vigilance.² Journal Of Clinical Neuroscience. Jul 7(4): 277-279. Colgan, S., N. Shilton, et al. (2000). ³Production of single species derived meat and bone meal - The development of laboratory-scale rendering (LSR) technique.² Fleischwirtschaft 80(4): 133-135. Collier, A. P., C. J. D. Hetherington, et al. (2000). ³Alignment mechanisms between particles in crystalline aggregates.² Journal Of Crystal Growth. 208(1-4): 513-519. Collins, S., A. Boyd, et al. (2000). ³Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease.² Archives Of Neurology. Jul 57(7): 1058-1063. Coustou, V., C. Deleu, et al. (1999). ³Mutational analysis of the [Het-s] prion analog of Podospora anserina: A short N-terminal peptide allows prion propagation.² Genetics . 153(4): 1629-1640. D' Haen, J., P. Cosemans, et al. (1999). ³Dynamics of electromigration induced void/hillock growth and precipitation/dissolution of addition elements studied by in-situ scanning electron microscopy resistance measurements.² Microelectronics Reliability. 39(11): 1617-1630. Dandoy Dron, F., L. Benboudjema, et al. (2000). ³Enhanced levels of scrapie responsive gene mRNA in BSE-infected mouse brain.² Molecular Brain Research. 76(1): 173-179. Daszak, P., A. A. Cunningham, et al. (2000). ³Wildlife ecology - Emerging infectious diseases of wildlife - Threats to biodiversity and human health.² Science . 287(5452): 443-449. Daude, N., S. Lehmann, et al. (2000). ³Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells (vol 272, pg 11604, 1997).² Journal Of Biological Chemistry. 275(2): 1520. Day, M. (2000). ³We're not safe yet - Only further testing will rule out an epidemic of human BSE.² New Scientist. 166(2237): 5. de Silva, R. N. (2000). ³Variant Creutzfeldt-Jakob disease: an update.² Hospital Medicine. 61(2): 82-83. Deptula, W. and M. Pawlikowska (2000). ³Pathogenesis of prion diseases.² Medycyna Weterynaryjna. 56(1): 11-14. Dermaut, B., M. Cruts, et al. (2000). ³Familial Creutzfeldt-Jakob disease in a patient carrying both a presenilin 1 missense substitution and a prion protein gene insertion.² Journal Of Neurology. 247(5): 364-368. Deschauer, M., M. Stephan, et al. (2000). ³Bilateral inferior hemianopsia as initial symptom in Creutzfeldt-Jakob disease (Heidenhain type).² Klinische Monatsblatter Fur Augenheilkunde. 216(4): 227-231. Dickson, D. W. and P. Brown (1999). ³Multiple prion types in the same brain - Is a molecular diagnosis of CJD possible?² Neurology . 53(9): 1903-1904. Dickson, D. (1999). ³Top BSE official forced to step down in UK.² Nature . 402(6764): 849. Dieter, R. S. (2000). ³Prion protein in tonsil and appendix tissue.² Lancet . 356(9228): 505. Dobbins, J. G., E. D. Belay, et al. (2000). ³Creutzfeldt-Jakob disease in a recipient of a dura mater graft processed in the US: Cause or coincidence?² Neuroepidemiology . 19(2): 62-66. Dobson, R. (2000). ³First results of vCJD survey show no signs of prion.² British Medical Journal. 320(7244): 1226. Doh Ura, K., T. Iwaki, et al. (2000). ³Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.² Journal Of Virology. 74(10): 4894-4897. Duckett, S. and J. Stern (1999). ³Origins of the Creutzfeldt and Jakob concept.² Journal of the History of the Neurosciences. 1999 ; Vol 8(1): 21-34. Duriez, O., H. Weimerskirch, et al. (2000). ³Regulation of chick provisioning in the thin-billed prion: an interannual comparison and manipulation of parents.² Canadian Journal Of Zoology Revue Canadienne De Zoologie. Jul 78(7): 1275-1283. Dzik, S., J. Aubuchon, et al. (2000). ³Leukocyte reduction of blood components: Public policy and new technology.² Transfusion Medicine Reviews. 14(1): 34-52. Echebarria, L. E. H., A. Saiz, et al. (2000). ³Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy.² Neurology . 54(7): 1539-1540. Eder, K. (2000). ³The transformation of the national public space in Europe. From the community of language to the issue-specific community of discourse.² Berliner Journal Fur Soziologie 10(2): 167-184. Edskes, H. K. and R. B. Wickner (2000). ³A protein required for prion generation: [URE3] induction requires the Ras-regulated Mks1 protein.² Proceedings Of The National Academy Of Sciences Of The United States Of America. Jun 97(12): 6625-6629. Esiri, M. M., J. Carter, et al. (2000). ³Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases.² Neuropathology And Applied Neurobiology. Jun 26(3): 273-284. Fernandez Bellot, E., E. Guillemet, et al. (2000). ³The yeast prion [URE3] can be greatly induced by a functional mutated URE2 allele.² Embo Journal. Jul 19(13): 3215-3222. Ferrer, I., B. Puig, et al. (2000). ³Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.² Neuroscience 97(4): 715-726. Finckh, U., T. Muller Thomsen, et al. (2000). ³High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.² American Journal Of Human Genetics. 66(1): 110-117. Forloni, G., M. Salmona, et al. (2000). ³Comment on: Neurotoxicity of prion peptide 106-126 not confirmed, by Beat Kunz, Erika Sandmeier, Philipp Christen - FEBS Letters 485 (1999) 65-68.² Febs Letters. 466(1): 205-206. Forloni, G., I. Bertani, et al. (2000). ³alpha-synuclein and Parkinson's disease: Selective neurodegenerative effect of alpha-synuclein fragment on dopaminergic neurons in vitro and in vivo.² Annals Of Neurology. 47(5): 632-640. Foster, P. R., C. McLean, et al. (2000). ³Removal of abnormal prion protein by plasma fractionation.² Transfusion Science. 22(1-2): 53-56. Fournier, J. G., F. Escaig Haye, et al. (2000). ³Ultrastructural localization of prion proteins: Physiological and pathological implications.² Microscopy Research And Technique. Jul 50(1): 76-88. Frederikse, P. H., J. S. Zigler, et al. (2000). ³Prion protein expression in mammalian lenses.² Current Eye Research. 20(2): 137-143. Frese, M., E. Teng, et al. (1999). ³Helping to improve suggestion systems: predictors of making suggestions in companies.² Journal Of Organizational Behavior. 20(7): 1139-1155. Galbete, J. L., T. Rodriguez Martin, et al. (2000). ³Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway.² Biochemical Journal. Jun 2: 307-313. Garcia, F. L., R. Zahn, et al. (2000). ³NMR structure of the bovine prion protein.² Proceedings Of The National Academy Of Sciences Of The United States Of America. Jul 97(15): 8334-8339. Garssen, G. J., L. J. M. Van Keulen, et al. (2000). ³Applicability of three anti-PrP peptide sera including staining of tonsils and brainstem of sheep with scrapie.² Microscopy Research And Technique. Jul 50(1): 32-39. Gass, C. S., C. A. Luis, et al. (2000). ³Familial Creutzfeldt-Jakob disease: A neuropsychological case study.² Archives Of Clinical Neuropsychology. 15(2): 165-175. Gayrard, V., N. Picard Hagen, et al. (2000). ³Major hypercorticism is an endocrine feature of ewes with naturally occurring scrapie.² Endocrinology . 141(3): 988-994. Giaccone, G., B. Canciani, et al. (2000). ³Creutzfeldt-Jakob disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein.² Brain Pathology. 10(1): 31-37. Giaccone, G., B. Canciani, et al. (2000). ³Creutzfeldt-Jakob Disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein. (vol 10, pg 31, 2000).² Brain Pathology. 10(2): 326-329. Gilch, S., C. Spielhaupter, et al. (2000). ³Shortest known prion protein allele in highly BSE-susceptible lemurs.² Biological Chemistry. Jun 381(5-6): 521-523. Giraud, P., A. Perret Liaudet, et al. (2000). ³Non familial Creutzfeldt-Jakob disease: a study of 53 cases.² Revue Neurologique. Jul 156(6-7): 616-621. Glatzel, M. and A. Aguzzi (2000). ³Peripheral pathogenesis of prion diseases.² Microbes And Infection. 2(6): 613-619. Glynn, A. and N. Glynn (1999). ³Plus ca change ... From rinderpest to bovine spongiform encephalopathy.² Journal Of The Royal College Of Physicians Of London. 33(6): 576-580. Goldsmith, J. C. (2000). ³Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates.² Blood Coagulation And Fibrinolysis. 11(2): 203-215. Graner, E., A. F. Mercadante, et al. (2000). ³Cellular prion protein binds laminin and mediates neuritogenesis.² Molecular Brain Research. 76(1): 85-92. Gravenor, M. B., D. R. Cox, et al. (2000). ³Encephalopathies - Scrapie in Britain during the BSE years.² Nature . 406(6796): 584-585. Haeberle, A. M., C. Ribaut Barassin, et al. (2000). ³Synaptic prion protein immuno-reactivity in the rodent cerebellum.² Microscopy Research And Technique. Jul 50(1): 66-75. Hagenaars, T. J., N. M. Ferguson, et al. (2000). ³Feed-borne transmission and case clustering of BSE.² Proceedings Of The Royal Society Of London Series B Biological Sciences. 267(1440): 205-215. Halim, N. S. (2000). ³Blocking prion formation.² Scientist . 14(5): 23. Hardt, M., T. Baron, et al. (2000). ³A comparative study of immunohistochemical methods for detecting abnormal prion protein with monoclonal and polyclonal antibodies.² Journal Of Comparative Pathology. 122(1): 43-53. Hardy, J. and A. Singleton (2000). ³The future of genetic analysis of neurological disorders.² Neurobiology Of Disease. 7(2): 65-69. Harris, D. A. (2000). ³Prion diseases.² Nutrition . Jul 16(7-8): 554-556. Hauw, J. J., V. Sazdovitch, et al. (2000). ³Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene.² Neurology . 54(8): 1641-1646. Head, M. W., L. Hurwitz, et al. (2000). ³alpha B-crystallin regulates intermediate filament organization in situ.² Neuroreport . 11(2): 361-365. Hegde, R. S., P. Tremblay, et al. (1999). ³Transmissible and genetic prion diseases share a common pathway of neurodegeneration.² Nature . 402(6763): 822-826. Herrmann, L. M., T. V. Baszler, et al. (2000). ³PrPc mRNA, but not PrPSc is found in the salivary glands of scrapie-infected sheep.² Biochimica Et Biophysica Acta Protein Structure And Molecular Enzymology. Jun 15: 1-2. Hinton, M. H. (2000). ³Infections and intoxications associated with animal feed and forage which may present a hazard to human health.² Veterinary Journal. 159(2): 124-138. Hofmann, K. (2000). ³Prophylaxis of BSE by controlling meat and bone meals - The ELISA heating test and the criterias for assessment.² Fleischwirtschaft 80(4): 140-143. Honig, J. F. and H. A. Merten (2000). ³Risk of transmission of agents associated with Creutzfeldt-Jakob disease and bovine spongiform encephalopathy - Reply.² Plastic And Reconstructive Surgery. 105(6): 2274-2275. Hope, J., S. Wood, et al. (2000). ³Molecular analysis of ovine prion protein identifies similarities between BSE and an experimental isolate of natural scrapie, CH1641 (vol 80, pg 1, 1999).² Journal Of General Virology. 3: 851. Hornsey, V., O. Drummond, et al. (2000). ³Leucofiltration, retention/generation of soluble prion and annexin V and storage of blood components.² Transfusion Science. 22(1-2): 75-76. Hoshino, S., N. Hosoda, et al. (1999). ³Novel function of the eukaryotic polypeptide-chain releasing factor 3 (eRF3/GSPT) in the mRNA degradation pathway.² Biochemistry Moscow. 64(12): 1367-1372. Howell, P. G. T. and A. Boyde (1999). ³Surface roughness of preparations for backscattered electron-scanning electron microscopy: The image differences and their Monte Carlo simulation.² Scanning . 21(6): 361-367. Huber, R., T. Deboer, et al. (2000). ³Effects of sleep deprivation on sleep and sleep EEG in three mouse strains: empirical data and simulations.² Brain Research. 857(1-2): 8-19. Ikeda, K., N. Kawada, et al. (1999). ³Expression of prion protein in activated hepatic stellate cells.² Cells Of The Hepatic Sinusoid 7: 21-23. Ilbery, B. and M. Kneafsey (2000). ³Producer constructions of quality in regional speciality food production: a case study from south west England.² Journal Of Rural Studies. 16(2): 217-230. Inouye, H., J. Bond, et al. (2000). ³Structural changes in a hydrophobic domain of the prion protein induced by hydration and by Ala -> Val and Pro -> Leu substitutions.² Journal Of Molecular Biology. Jul 300(5): 1283-1296. Ironside, J. W., D. A. Hilton, et al. (2000). ³Retrospective study of prion-protein accumulation in tonsil and appendix tissues.² Lancet . 355(9216): 1693-1694. Jackson, G. S. and A. R. Clarke (2000). ³Mammalian prion proteins.² Current Opinion In Structural Biology. 10(1): 69-74. Janssen, J. C., P. L. Lantos, et al. (2000). ³Thalamic degeneration with negative prion protein immunostaining.² Journal Of Neurology. 247(1): 48-51. Jeffrey, M. and J. R. Fraser (2000). ³Tubulovesicular particles occur early in the incubation period of murine scrapie.² Acta Neuropathologica. 99(5): 525-528. Jeffrey, M., G. McGovern, et al. (2000). ³Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immune-electron microscopy.² Journal Of Pathology. Jul 191(3): 323-332. Johnson, W. G. (2000). ³Late-onset neurodegenerative diseases - the role of protein insolubility.² Journal Of Anatomy. 4: 609-616. Kane, M. D., W. J. Lipinski, et al. (2000). ³Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice.² Journal Of Neuroscience. 20(10): 3606-3611. Kaneko, K., H. L. Ball, et al. (1999). ³A synthetic peptide initiates Gerstmann-Straussler-Scheinker (GSS) disease in transgenic mice.² Journal Of Molecular Biology. 295(4): 997-1007. Keohane, C. (2000). ³Pulvinar sign on MRI images in variant Creutzfeldt-Jakob disease.² Lancet . 355(9213): 1384. Kimura, K., M. Kubo, et al. (2000). ³Characteristics of prion protein (PrPSc) in the brains of hamsters inoculated serially with a mouse-passaged scrapie strain.² Journal Of Comparative Pathology. 122(2-3): 123-130. Kisselev, L. L. (1999). ³Translation termination and yeast prions - (Introductory remarks of the guest editor of this special issue).² Biochemistry Moscow. 64(12): 1337-1341. Kneipp, J., P. Lasch, et al. (2000). ³Detection of pathological molecular alterations in scrapie-infected hamster brain by Fourier transform infrared (FT-IR) spectroscopy.² Biochimica Et Biophysica Acta Molecular Basis Of Disease. Jun 15: 2-3. Knight, R. (2000). ³Therapeutic possibilities in CJD: patents 1996-1999.² Expert Opinion On Therapeutic Patents. 10(1): 49-57. Komar, A. A., R. Melki, et al. (1999). ³The [URE3] yeast prion: from genetics to biochemistry.² Biochemistry Moscow. 64(12): 1401-1407. Kopacek, J., S. Sakaguchi, et al. (2000). ³Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease.² Journal Of Virology. 74(1): 411-417. Kourie, J. I. and A. A. Shorthouse (2000). ³Properties of cytotoxic peptide-formed ion channels.² American Journal Of Physiology Cell Physiology. Jun 278(6): C1063-C1087. Krebs, M. R. H., D. K. Wilkins, et al. (2000). ³Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain.² Journal Of Molecular Biology. Jul 300(3): 541-549. Kropp, S., M. Finkenstaedt, et al. (2000). ³Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease.² Nervenarzt . 71(2): 91-95. Kropp, S., J. Schlimme, et al. (2000). ³Diagnostic steps in possible Alzheimer dementia before starting with new therapeutics.² Fortschritte Der Neurologie Psychiatrie. Jun 68(6): 257-261. Kropp, S., C. Riedemann, et al. (2000). ³Attitude of Creutzfeldt-Jakob disease relatives towards dementia research.² Psychiatrische Praxis. Jul 27(5): 248-251. Kubosaki, A., A. Ueno, et al. (2000). ³Analysis of prion protein mRNA by in situ hybridization in brain and placenta of sheep.² Biochemical And Biophysical Research Communications. Jul 273(3): 890-893. Kuner, P., B. Bohrmann, et al. (2000). ³Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands.² Journal Of Biological Chemistry. 275(3): 1673-1678. Kushnirov, V. V., N. Kochneva Pervukhova, et al. (2000). ³Prion properties of the Sup35 protein of yeast Pichia methanolica.² Embo Journal. 19(3): 324-331. Kuwahara, C., A. Kubosaki, et al. (2000). ³Enhanced expression of cellular prion protein gene by insulin or nerve growth factor in immortalized mouse neuronal precursor cell lines.² Biochemical And Biophysical Research Communications. 268(3): 763-766. Lang, N. P., C. Hammerle, et al. (2000). ³Risk of transmission of agents associated with Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.² Plastic And Reconstructive Surgery. 105(6): 2273-2274. Laplanche, J. L., K. H. El Hachimi, et al. (1999). ³Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene.² Brain . 12: 2375-2386. Lee, H. G., S. J. Park, et al. (1999). ³Increased expression of prion protein is associated with changes in dopamine metabolism and MAO activity in PC12 cells.² Journal Of Molecular Neuroscience. 13(1-2): 121-126. Lehmann, S. and D. A. Harris (2000). ³A mutant prion protein displays an aberrant membrane association when expressed in cultured cells (vol 270, pg 24589, 1995).² Journal Of Biological Chemistry. 275(2): 1520. Lehmann, S. and D. A. Harris (2000). ³Mutant and infectious prion proteins display common biochemical properties in cultured cells (vol 271, 1633, 1996).² Journal Of Biological Chemistry. 275(2): 1520. Leuba, G., K. Saini, et al. (2000). ³Early-onset familial Alzheimer disease with coexisting beta-amyloid and prion pathology.² Jama Journal Of The American Medical Association. 283(13): 1689-1691. Leuck, C. J., G. G. McIlwaine, et al. (2000). ³Creutzfeldt-Jakob disease and the eye. I. Background and patient management.² Eye . Jun 14: 263-290. Li, L. M. and S. Lindquist (2000). ³Creating a protein-based element of inheritance.² Science . 287(5453): 661-664. Li, A. M., S. Sakaguchi, et al. (2000). ³Identification of a novel gene encoding a PrP-like protein expressed as chimeric transcripts fused to PrP exon 1/2 in ataxic mouse line with a disrupted PrP gene.² Cellular And Molecular Neurobiology. 20(5): 553-567. Liang, Y. and K. Sasaki (2000). ³Expression of adhesion molecules relevant to leukocyte migration on the microvilli of liver peritoneal mesothelial cells.² Anatomical Record. 258(1): 39-46. Liberski, P. P. and M. Jeffrey (2000). ³Tubulovesicular structures: What are they really?² Microscopy Research And Technique. Jul 50(1): 46-57. Liberski, P. P., J. Bratosiewicz, et al. (2000). ³A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Straussler-Scheinker phenotype but no alterations in the PRNP gene.² Acta Neuropathologica. 100(2): 233-234. Liu, A. Z., R. Riek, et al. (2000). ³NMR experiments for resonance assignments of C-13, N-15 doubly-labeled flexible polypeptides: Application to the human prion protein hPrP(23-230).² Journal Of Biomolecular Nmr. 16(2): 127-138. Love, S., C. R. Helps, et al. (2000). ³Methods for detection of haematogenous dissemination of brain tissue after stunning of cattle with captive bolt guns.² Journal Of Neuroscience Methods. Jun 99(1-2): 53-58. Lowe, J. (2000). ³Evidence of a CJD epidemic may still be missed.² British Medical Journal. 320(7240): 1011. Lubell, A. S., H. G. L. Prion, et al. (2000). ³Unstiffened steel plate shear wall performance under cyclic loading.² Journal Of Structural Engineering Asce. 126(4): 453-460. Lueck, C. J., G. G. McIlwaine, et al. (2000). ³Creutzfeldt-Jakob disease and the eye. II. Ophthalmic and neuro-ophthalmic features.² Eye . Jun 14: 291-301. Mabbott, N. A., A. Williams, et al. (2000). ³Tumor necrosis factor alpha-deficient, but not mterleukin-6-deficient, mice resist peripheral infection with scrapie.² Journal Of Virology. 74(7): 3338-3344. Mabbott, N. A., F. Mackay, et al. (2000). ³Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie.² Nature Medicine. Jul 6(7): 719-720. MacGregor, I., O. Drummond, et al. (2000). ³Distribution of normal prion protein in blood.² Transfusion Science. 22(1-2): 51. MacKenzie, D. (2000). ³Wurst case scenario - Lovers of German sausage risk exposure to BSE.² New Scientist. 165(2228): 7. MacKenzie, D. (2000). ³Woolly thinking - BSE in American sheep? It's "far-fetched speculation" say experts.² New Scientist. Jul 167(2248): 5. MacPhee, C. E. and C. M. Dobson (2000). ³Chemical dissection and reassembly of amyloid fibrils formed by a peptide fragment of transthyretin.² Journal Of Molecular Biology. 297(5): 1203-1215. Madec, J. Y., P. Belli, et al. (2000). ³Efficiency of Western blotting for the specific immunodection of proteinase K-resistant prion protein in BSE diagnosis in France.² Veterinary Record. 146(3): 74-76. Majeed, A., P. Lehmann, et al. (2000). ³Extent of misclassification of death from Creutzfeldt-Jakob disease in England 1979-96: retrospective examination of clinical records.² British Medical Journal. 320(7228): 145-147. Mange, A., N. Nishida, et al. (2000). ³Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures.² Journal Of Virology. 74(7): 3135-3140. Mange, A., O. Milhavet, et al. (2000). ³Effect of amphotericin B on wild-type and mutated prion proteins in cultured cells: Putative mechanism of action in transmissible spongiform encephalopathies.² Journal Of Neurochemistry. 74(2): 754-762. Manousis, T., S. Verghese Nikolakaki, et al. (2000). ³Characterization of the murine BSE infectious agent.² Journal Of General Virology. Jun 6: 1615-1620. Manson, J. C., E. Jamieson, et al. (1999). ³A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy.² Embo Journal. 18(23): 6855-6864. Manunta, M., B. Kunz, et al. (2000). ³Reported channel formation by prion protein fragment 106-126 in planar lipid bilayers cannot be reproduced.² Febs Letters. Jun 474(2-3): 255-256. Manzoni, M., S. Bergomi, et al. (2000). ³Extracellular K5 polysaccharidic antigen recovery performed by different cell separation technologies.² Biotechnology Letters. 22(9): 759-766. Marciani, M. G., G. Bernardi, et al. (1996). ³Rapidly progressive form of Creutzfeldt-Jakob disease without dementia: A case report.² International Journal of Neuroscience. 1996 ; Vol 84(1-4): 115-120. Markham, D. (2000). ³Prion protein in tonsil and appendix tissue.² Lancet . 356(9228): 505-506. Martinez Yamout, M., G. B. Legge, et al. (2000). ³Solution structure of the cysteine-rich domain of the Escherichia coli chaperone protein DnaJ.² Journal Of Molecular Biology. Jul 300(4): 805-818. Masliah, E. and E. Rockenstein (2000). ³Genetically altered transgenic models of Alzheimer's disease.² Journal Of Neural Transmission Supplement 59: 175-183. Mateos, V., S. Calleja, et al. (2000). ³Value of electroencephalogram in the evaluation of patients with suspicion of espongiform leukoencephalopathy.² Medicina Clinica. 114(3): 116-117. Matsunga, T. and K. Akimoto (2000). ³Vaccines not containing human albumin and vaccines to avoid the risk of Creutzfeldt-Jakob disease.² European Journal Of Pediatrics. 159(3): 222. Mayeux Portas, V., S. E. File, et al. (2000). ³Mice lacking the cell adhesion molecule Thy-1 fail to use socially transmitted cues to direct their choice of food.² Current Biology. 10(2): 68-75. McHattie, S. J., D. R. Brown, et al. (1999). ³Cellular uptake of the prion protein fragment PrP106-126 in vitro.² Journal Of Neurocytology. 28(2): 149-159. McParland, V. J., N. M. Kad, et al. (2000). ³Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro.² Biochemistry . 39(30): 8735-8746. Medley, G. F. (2000). ³Statistical aspects of BSE and vCJD: Models for epidemics.² Nature . 403(6766): 138. Milhavet, O., A. Mange, et al. (2000). ³Effect of Congo red on wild-type and mutated prion proteins in cultured cells.² Journal Of Neurochemistry. 74(1): 222-230. Mitrova, E. and G. Belay (2000). ³Creutzfeldt-Jakob disease in health professionals in Slovakia.² European Journal Of Epidemiology. 16(4): 353-355. Miura, T., K. Suzuki, et al. (2000). ³Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.² Biochemistry . Jun 39(23): 7024-7031. Molloy, S., O. L. R, et al. (2000). ³The "pulvinar" sign in variant Creutzfeldt-Jakob Disease.² American Journal Of Roentgenology. 175(2): 555-556. Monoi, H., S. Futaki, et al. (2000). ³Poly-(L)-glutamine forms cation channels: Relevance to the pathogenesis of the polyglutamine diseases.² Biophysical Journal. Jun 78(6): 2892-2899. Moreau, M. F., Y. Gallois, et al. (2000). ³Gamma irradiation of human bone allografts alters medullary lipids and releases toxic compounds for osteoblast-like cells.² Biomaterials . 21(4): 369-376. Moretti, R., P. Torre, et al. (2000). ³Diagnostic instruments for Creutzfeldt-Jacob's disease.² European Journal Of Neurology. 7(3): 363-364. Morillas, M., W. Swietnicki, et al. (1999). ³Membrane environment alters the conformational structure of the recombinant human prion protein.² Journal Of Biological Chemistry. 274(52): 36859-36865. Moser, M. and B. Oesch (2000). ³Prionics AG - Ahead of the competition in diagnosing BSE.² Chimia 54(4): 203-204. Moya, K. L., N. Sales, et al. (2000). ³Immunolocalization of the cellular prion protein in normal brain.² Microscopy Research And Technique. Jul 50(1): 58-65. Mugnier, P. and M. F. Tuite (1999). ³Translation termination and its regulation in eukaryotes: Recent insights provided by studies in yeast.² Biochemistry Moscow. 64(12): 1360-1366. Muramoto, T., T. Tanaka, et al. (2000). ³Analyses of Gerstmann-Straussler syndrome with 102Leu219Lys using monoclonal antibodies that specifically detect human prion protein with 219Glu.² Neuroscience Letters. Jul 288(3): 179-182. Nailon, W. H. and J. W. Ironside (2000). ³Variant Creutzfeldt-Jakob disease: Immunocytochemical studies and image analysis.² Microscopy Research And Technique. Jul 50(1): 2-9. Nakamura, N., Y. Aoki, et al. (2000). ³Construction of recombinant monoclonal antibodies from a chicken hybridoma line secreting specific antibody.² Cytotechnology . 32(3): 191-198. Nishida, Y. and S. Nishino (1999). ³Contribution of a metal-peroxide adduct to neurodegeneration is due to its oxidative protease activity.² Zeitschrift Fur Naturforschung C A Journal Of Biosciences. 54(12): 1107-1114. Nishida, N., D. A. Harris, et al. (2000). ³Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.² Journal Of Virology. 74(1): 320-325. Nooijen, P. T. G. A., H. C. Schoonderwaldt, et al. (1997). ³Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia.² Dementia and Geriatric Cognitive Disorders. 1997 Jun; Vol 8(3): 169-173. O' Doherty, E., M. Aherne, et al. (2000). ³Detection of polymorphisms in the prion protein gene in a population of Irish Suffolk sheep.² Veterinary Record. 146(12): 335-338. Oppenheim, C., J. P. Brandel, et al. (2000). ³MRI and the second French case of vCJD.² Lancet . Jul 356(9225): 253-254. Pammer, J., H. S. Cross, et al. (2000). ³The pattern of prion-related protein expression in the gastrointestinal tract.² Virchows Archiv An International Journal Of Pathology. 436(5): 466-472. Parchi, P., S. Capellari, et al. (2000). ³Intracerebral distribution of the abnormal isoform of the prion protein in sporadic Creutzfeldt-Jakob disease and fatal insomnia.² Microscopy Research And Technique. Jul 50(1): 16-25. Parchment, O. G. and J. W. Essex (2000). ³Molecular dynamics of mouse and syrian hamster PrP: Implications for activity.² Proteins Structure Function And Genetics. 38(3): 327-340. Park, S., L. Wanna, et al. (2000). ³A mass spectrometry screening method for antiaggregatory activity of proteins covalently modified by combinatorial library members: Application to sickle hemoglobin.² Journal Of Combinatorial Chemistry. Jul 2(4): 314-317. Parmar, J. S. and D. A. Lomas (2000). ³Alpha-1-antitrypsin deficiency, the serpinopathies and conformational disease.² Journal Of The Royal College Of Physicians Of London. Jun 34(3): 295-300. Parren, P., P. Poignard, et al. (2000). ³Antibodies in human infectious disease.² Immunologic Research 21(2-3): 265-278. Patry, D., B. Curry, et al. (1998). ³Creutzfeldt-Jakob disease (CJD) after blood product transfusion from a donor with CJD.² Neurology. 1998 Jun; Vol 50(6): 1872-1873-. Peano, S., G. Reiner, et al. (2000). ³Determination of the clearance factor for transmissible spongiform encephalopathy agents during the manufacturing process of polygeline.² Intensive Care Medicine. 26(5): 608-612. Petraroli, R., G. Vaccari, et al. (2000). ³A rapid and efficient method for the detection of point mutations of the human prion protein gene (PRNP) by direct sequencing.² Journal Of Neuroscience Methods. Jun 99(1-2): 59-63. Pfenning, D. W. (2000). ³Effect of predator-prey phylogenetic similarity on the fitness consequences of predation: A trade-off between nutrition and disease?² American Naturalist. 155(3): 335-345. Phillips, S. C., J. W. Essex, et al. (2000). ³Digitally filtered molecular dynamics: The frequency specific control of molecular dynamics simulations.² Journal Of Chemical Physics. 112(6): 2586-2597. Pieiller, E. (1999). ³'Contes Immoraux', followed by 'Mes Ecarts ou Ma Tete en Liberte'.² Quinzaine Litteraire. 31(775): 26. Polak, M. P. and J. F. Zmudzinski (2000). ³The latest information concerning laboratory diagnosis of transmissible spongiform encephalopathies - TSEs.² Medycyna Weterynaryjna. 56(4): 211-213. Polak, M. P. and J. F. Zmudzinski (2000). ³Diagnosis of transmissible spongiform encephalopathies.² Medycyna Weterynaryjna. 56(3): 143-149. Politopoulou, G., J. D. Seebach, et al. (2000). ³Age-related expression of the cellular prion protein in human peripheral blood leukocytes.² Haematologica . Jun 85(6): 580-587. Porcher, E. and M. Gatto (2000). ³Quantifying the dynamics of prion infection: a bifurcation analysis of Laurent's model.² Journal Of Theoretical Biology. Jul 205(2): 283-296. Porter, S., C. Scully, et al. (2000). ³The human transmissible spongiform encephalopathies (TSEs): implications for dental practitioners.² British Dental Journal. 188(8): 432-436. Poser, S., B. Mollenhauer, et al. (1999). ³How to improve the clinical diagnosis of Creutzfeldt-Jakob disease.² Brain . 12: 2345-2351. Priola, S. A., A. Raines, et al. (2000). ³Porphyrin and phthalocyanine antiscrapie compounds.² Science . 287(5457): 1503-1506. Privat, N., V. Sazdovitch, et al. (2000). ³PrP immunohistochemistry: Different protocols, including a procedure for long formalin fixation, and a proposed schematic classification for deposits in sporadic Creutzfeldt-Jakob disease.² Microscopy Research And Technique. Jul 50(1): 26-31. Puoti, G., G. Giaccone, et al. (1999). ³Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrPSc in the same brain.² Neurology . 53(9): 2173-2176. Puoti, G., G. Rossi, et al. (2000). ³Polymorphism at codon 129 of PRNP, affects the phenotypic expression of Creutzfeldt-Jakob disease linked to E200K mutation.² Annals Of Neurology. 48(2): 269-270. Purdey, M. (2000). ³Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Co, Se, Fe, Zn - Does a foreign cation substitution at prion protein's Cu domain initiate TSE?² Medical Hypotheses. 54(2): 278-306. Qin, K. F., D. S. Yang, et al. (2000). ³Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP - Effect of protein age and deamidation.² Journal Of Biological Chemistry. Jun 275(25): 19121-19131. Raeber, A. J. and A. Aguzzi (2000). ³Engulfment of prions in the germinal centre.² Immunology Today. 21(2): 66-67. Ragnarsdottir, K. V. (2000). ³Environmental fate and toxicology of organophosphate pesticides.² Journal Of The Geological Society. Jul 4: 859-876. Ridley, R. M. (2000). ³Variant CJD: finding a needle in a haystack?² Hospital Medicine. 61(2): 145. Rogers, M., D. Doyle, et al. (2000). ³Prions: strategies for control of BSE and scrapie.² Irish Journal Of Agricultural And Food Research. Jun 39(2): 229-234. Rohlff, C. (2000). ³Proteomics in molecular medicine: Applications in central nervous systems disorders.² Electrophoresis . 21(6): 1227-1234. Rossi, F. and J. F. Legras (2000). ³Viral safety: European and French directives.² Annales De Medecine Interne. 1: 55-61. Rowe, G., L. Frewer, et al. (2000). ³Newspaper reporting of hazards in the UK and Sweden.² Public Understanding Of Science. 9(1): 59-78. Rudyk, H., S. Vasiljevic, et al. (2000). ³Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells.² Journal Of General Virology. 4: 1155-1164. Ruiz, F. H., E. Silva, et al. (2000). ³The N-terminal tandem repeat region of human prion protein reduces copper: Role of tryptophan residues.² Biochemical And Biophysical Research Communications. 269(2): 491-495. Ryder, S. J., S. A. C. Hawkins, et al. (2000). ³The neuropathology of experimental bovine spongiform encephalopathy in the pig.² Journal Of Comparative Pathology. 122(2-3): 131-143. Saegerman, C., P. Dechamps, et al. (1999). ³Epidemiosurveillance of bovine spongiform encephalopathy in Belgium during 1998.² Annales De Medecine Veterinaire. 143(6): 423-435. Saiz, A., F. Graus, et al. (2000). ³14-3-3 cerebrospinal fluid protein and Creutzfeldt-Jakob disease - Reply.² Annals Of Neurology. 47(5): 684. Sakurai, A., K. Okamoto, et al. (2000). ³Fragmentation of the Golgi apparatus of the ballooned neurons in patients with corticobasal degeneration and Creutzfeldt-Jakob disease.² Acta Neuropathologica. 100(3): 270-274. Salzberger, B., C. Franzen, et al. (2000). ³Update in infectious diseases. Part I: Epidemiology.² Medizinische Klinik. Jun 95(6): 314-320. Santoso, A., P. Chien, et al. (2000). ³Molecular basis of a yeast prion species barrier.² Cell . 100(2): 277-288. Sastry, P. (2000). ³Transmissible spongiform encephalopathies and the 'rogue share-holder protein' hypothesis.² Medical Hypotheses. 54(2): 186-188. Sauer, H., A. Dagdanova, et al. (1999). ³Redox-regulation of intrinsic prion expression in multicellular prostate tumor spheroids.² Free Radical Biology And Medicine. 27(11-12): 1276-1283. Sax, H. and D. Pittet (2000). ³Disinfectants that do.² Current Opinion In Infectious Diseases. 13(4): 395-399. Sayre, L. M., G. Perry, et al. (2000). ³The role of metals in neurodegenerative diseases.² Cellular And Molecular Biology. Jun 46(4): 731-741. Schamall, D., M. Teschler Nicola, et al. (1999). ³Differential diagnosis on ancient skeletal remains: Conventional methods and novel application of the BSE-mode in SEM on a skull tumor of the early Bronze Age.² Collegium Antropologicum. 23(2): 483-494. Schell, J., M. Wulfert, et al. (1999). ³Detection of point mutations by capillary electrophoresis with temporal temperature gradients.² Electrophoresis . 20(14): 2864-2869. Schladitz, C., E. P. Vieira, et al. (1999). ³Amyloid-beta-sheet formation at the air-water interface.² Biophysical Journal. 77(6): 3305-3310. Schlapfer, J., N. Saitbekova, et al. (1999). ³A new allelic variant in the bovine prion protein gene (PRNP) coding region.² Animal Genetics. 30(5): 386-387. Schlapfer, J., N. Stahlberger Saitbekova, et al. (2000). ³Genetic mapping of the prion protein gene (PRNP) on bovine chromosome 13.² Journal Of Animal Breeding And Genetics Zeitschrift Fur Tierzuchtung Und Zuchtungsbiologie. Jun 117(3): 211-216. Schlumpberger, M., H. Wille, et al. (2000). ³The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein.² Protein Science. 9(3): 440-451. Schulz, J. B. and J. Dichgans (1999). ³Molecular pathogenesis of movement disorders: are protein aggregates a common link in neuronal degeneration?² Current Opinion In Neurology. 12(4): 433-439. Schulz Schaeffer, W. J., S. Tschoke, et al. (2000). ³The paraffin-embedded tissue blot detects PrPSC early in the incubation time in prion diseases.² American Journal Of Pathology. 156(1): 51-56. Scott, M. R., R. Will, et al. (1999). ³Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans.² Proceedings Of The National Academy Of Sciences Of The United States Of America. 96(26): 15137-15142. Scrimgeour, E. M., F. R. Mehta, et al. (1999). ³Infectious and tropical diseases in Oman: A review.² American Journal Of Tropical Medicine And Hygiene. 61(6): 920-925. Seghatchian, J. (2000). ³The Second International Forum on variant CJD and leucodepletion: UK.² Transfusion Science. 22(1-2): 45-46. Senior, K. (2000). ³Alzheimer's and prion disease; do they share a pathogenic mechanism?² Lancet . 355(9213): 1434. Senior, K. (2000). ³beta-Sheet breaking peptide might treat prion disease.² Drug Discovery Today. 5(5): 175-176. Seno, H., H. Tashiro, et al. (2000). ³New haplotype of familial Creutzfeldt-Jakob disease with a codon 200 mutation and a codon 219 polymorphism of the prion protein gene in a Japanese family.² Acta Neuropathologica. 99(2): 125-130. Serio, T. R. and S. L. Lindquist (1999). ³[PSI+]: An epigenetic modulator of translation termination efficiency.² Annual Review Of Cell And Developmental Biology 15: 661-703. Serio, T. R. and S. L. Lindquist (2000). ³Protein-only inheritance in yeast: something to get [PSI+]-ched about.² Trends In Cell Biology. 10(3): 98-105. Sharief, M. K., A. Green, et al. (1999). ³Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease.² Neurology. 1999 ; Vol 52(6): 1289-1291. Shinobu, L. A. (2000). ³Case 28-1999: Creutzfeldt-Jakob disease - Reply.² New England Journal Of Medicine. 342(4): 292-293. Shiraishi, N., Y. Ohta, et al. (2000). ³The octapeptide repeat region of prion protein binds Cu(II) in the redox-inactive state.² Biochemical And Biophysical Research Communications. 267(1): 398-402. Shyu, W. C., M. C. Kao, et al. (2000). ³Heat shock modulates prion protein expression in human NT-2 cells.² Neuroreport . 11(4): 771-774. Sicard, D. (2000). ³Blood transfusion and principle of precaution.² Transfusion Clinique Et Biologique. Jun 7(3): 220-227. Sideraki, V. and H. F. Gilbert (2000). ³Mechanism of the antichaperone activity of protein disulfide isomerase: Facilitated assembly of large, insoluble aggregates of denatured lysozyme and PDI.² Biochemistry . 39(5): 1180-1188. Silvestri, G. and F. Baldassarre (2000). ³Prion diseases: a typical Kuhnian abnormality in a molecular paradigm.² Medical Hypotheses. 54(1): 69-71. Simmons, M. M., S. J. Ryder, et al. (2000). ³Scrapie surveillance in Great Britain: results of an abattoir survey, 1997/98.² Veterinary Record. 146(14): 391-395. Simon, E. S., E. Kahana, et al. (2000). ³Creutzfeldt-Jakob disease profile in patients homozygous for the PRNP E200K mutation.² Annals Of Neurology. 47(2): 257-260. Sinclair, C. J. D., P. N. Shepel, et al. (2000). ³Stimulation of nucleoside efflux and inhibition of adenosine kinase by A(1) adenosine receptor activation.² Biochemical Pharmacology. 59(5): 477-483. Smith, G. and R. Charlton (2000). ³New-variant Creutzfeldt-Jakob disease.² British Journal Of General Practice. 50(457): 611-612. Sondheimer, N. and S. Lindquist (2000). ³Rnq1: An epigenetic modifier of protein function in yeast.² Molecular Cell. 5(1): 163-172. Soto, C., R. J. Kascsak, et al. (2000). ³Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides.² Lancet . 355(9199): 192-197. Sparrer, H. E., A. Santoso, et al. (2000). ³Evidence for the prion hypothesis: Induction of the yeast [PSI+] factor by in vitro-converted Sup35 protein.² Science . Jul 289(5479): 595-599. Supattapone, S., H. O. B. Nguyen, et al. (1999). ³Elimination of prions by branched polyamines and implications for therapeutics.² Proceedings Of The National Academy Of Sciences Of The United States Of America. 96(25): 14529-14534. Svensson, M., A. Hakansson, et al. (2000). ³Conversion of alpha-lactalbumin to a protein inducing apoptosis.² Proceedings Of The National Academy Of Sciences Of The United States Of America. 97(8): 4221-4226. Sweeney, T., T. Kuczius, et al. (2000). ³Molecular analysis of Irish sheep scrapie cases.² Journal Of General Virology. Jun 6: 1621-1627. Sweeney, T., T. Kuczius, et al. (2000). ³Molecular analysis of Irish sheep scrapie cases (vol 81, pg 1621, 2000).² Journal Of General Virology. 8: 2121. Swietnicki, W., M. Morillas, et al. (2000). ³Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.² Biochemistry . 39(2): 424-431. Sy, M. S. and P. Gambetti (1999). ³Prion replication - once again blaming the dendritic cell.² Nature Medicine. 5(11): 1235-1237. Systchenko, R., B. Marchetti, et al. (2000). ³Guidelines for cleaning and disinfection protocols for digestive tract endoscopes.² Gastroenterologie Clinique Et Biologique. 24(5): 520-529. Tacke, V. (2000). ³Uncertainty absorption in risk-tasking. Comparing constructivist observations of risks from BSE.² Zeitschrift Fur Soziologie. 29(2): 83-102. Tagliavini, F., G. Forloni, et al. (2000). ³Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro.² Journal Of Molecular Biology. Jul 300(5): 1309-1322. Taniwaki, Y., H. Hara, et al. (2000). ³Familial Creutzfeldt-Jakob disease with D178N-129M mutation of PRNP presenting as cerebellar ataxia without insomnia.² Journal Of Neurology Neurosurgery And Psychiatry. 68(3): 388. Tatzelt, J., D. F. Groth, et al. (1999). ³Kinetics of prion protein accumulation in the CNS of mice with experimental scrapie.² Journal Of Neuropathology And Experimental Neurology. 58(12): 1244-1249. Taylor, D. M. (1999). ³Inactivation of prions by physical and chemical means.² Journal Of Hospital Infection. 43: S69-S76. Taylor, D. M. (2000). ³Inactivation of transmissible degenerative encephalopathy agents: A review.² Veterinary Journal. 159(1): 10-17. Telling, G. C. (2000). ³Prion protein genes and prion diseases: studies in transgenic mice.² Neuropathology And Applied Neurobiology. Jun 26(3): 209-220. Tenidis, K., M. Waldner, et al. (1999). ³Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.² Journal Of Molecular Biology. 295(4): 1055-1071. Ter Avanesyan, M. D. and V. V. Kushnirov (1999). ³Prions: Infectious proteins with genetic properties.² Biochemistry Moscow. 64(12): 1382-1390. Thibier, M. and B. Guerin (2000). ³Embryo transfer in small ruminants: the method of choice for health control in germplasm exchanges.² Livestock Production Science. 62(3): 253-270. Timperley, W. R. (2000). ³Neuropathology.² Journal Of Clinical Pathology. 53(4): 255-265. Tuite, M. F. (1999). ³Yeast prions and their prion-forming domain.² Cell . 100(3): 289-292. Tuite, M. F. (2000). ³Cell biology - Sowing the protein seeds of prion propagation.² Science . Jul 289(5479): 556-557. Tullo, A., R. Buckley, et al. (2000). ³CJD and the eye.² Eye . Jun 14: 259-260. Turner, M. L. and C. A. Ludlam (2000). ³Variant Creutzfeldt-Jakob disease.² Transfusion Medicine Reviews. Jul 14(3): 216-222. Vajda, E. G., S. Humphrey, et al. (1999). ³Influence of topography and specimen preparation on backscattered electron images of bone.² Scanning . 21(6): 379-387. Valleron, A. J. (2000). ³Roles of mathematical modelling in epidemiology.² Comptes Rendus De L Academie Des Sciences Serie Iii Sciences De La Vie Life Sciences. 323(5): 429-433. van der Riet, F. D. J. (2000). ³Diseases of plants transmissible between plants and man (Phytonoses) exist - follow-up paper.² Medical Hypotheses. 54(2): 310-311. Van Everbroeck, B., K. I. O' Rourke, et al. (1999). ³Immunoreactivity of the monoclonal antibody F89/160.1.5 for human prion protein.² European Journal Of Histochemistry 43(4): 335-338. Van Everbroeck, B., P. Pals, et al. (2000). ³Retrospective study of Creutzfeldt-Jakob disease in Belgium: neuropathological findings.² Acta Neuropathologica. 99(4): 358-364. van Rijk, A. F. and H. Bloemendal (1999). ³Alpha-B-crystallin in neuropathology.² Ophthalmologica . 214(1): 7-12. Verbeke, W., J. Viaene, et al. (1999). ³Health communication and consumer behavior on meat in Belgium: From BSE until dioxin.² Journal Of Health Communication. 4(4): 345-357. Vilette, D., M. F. Madelaine, et al. (2000). ³Establishment of astrocyte cell lines from sheep genetically susceptible to scrapie.² In Vitro Cellular And Developmental Biology Animal. 36(1): 45-49. Volkov, K. V., K. Kurishko, et al. (2000). ³Polymorphism of the SUP35 gene and its product in the yeast Saccharomyces cerevisiae.² Russian Journal Of Genetics. 36(2): 102-105. Vorbrodt, A. W., D. H. Dobrogowska, et al. (1999). ³Immunogold study of regional differences in the distribution of glucose transporter (GLUT-1) in mouse brain associated with physiological and accelerated aging and scrapie infection.² Journal Of Neurocytology. 28(9): 711-719. Vrancken, A., C. J. M. Frijns, et al. (2000). ³FLAIR MRI in sporadic Creutzfeldt-Jakob disease.² Neurology . Jul 55(1): 147-148. Waggoner, D. J., B. Drisaldi, et al. (2000). ³Brain copper content and cuproenzyme activity do not vary with prion protein expression level.² Journal Of Biological Chemistry. 275(11): 7455-7458. Walker, M. (2000). ³A lesser evil - Human BSE may kill thousands, but it could have been worse.² New Scientist. 165(2222): 5. Walsh, D. T., V. H. Perry, et al. (2000). ³Cyclooxygenase-2 is highly expressed in microglial-like cells in a murine in model of prion disease.² Glia . 29(4): 392-396. Walz, R., O. B. Amaral, et al. (1999). ³Increased sensitivity to seizures in mice lacking cellular prion protein.² Epilepsia . 40(12): 1679-1682. Wang, J. H. C. (2000). ³Substrate deformation determines actin cytoskeleton reorganization: A mathematical modeling and experimental study.² Journal Of Theoretical Biology. 202(1): 33-41. Wenisch, S., E. Lucker, et al. (2000). ³Procedures for the unwanted ingredients in meat products with regard to BSE - 4. Histological and immunohistological procedures for the detection of central nervous tissue in meat products.² Fleischwirtschaft 80(7): 69-72. Whittal, R. M., H. L. Ball, et al. (2000). ³Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry.² Protein Science. 9(2): 332-343. Wickner, R. B., K. L. Taylor, et al. (1999). ³Prions in Saccharomyces and Podospora spp.: Protein-based inheritance.² Microbiology And Molecular Biology Reviews. 63(4): 844-861. Wientjens, D., B. Rikken, et al. (2000). ³A nationwide cohort study on Creutzfeldt-Jakob disease among human growth hormone recipients.² Neuroepidemiology . Jul 19(4): 201-205. Will, R. G., M. Zeidler, et al. (2000). ³Diagnosis of new variant Creutzfeldt-Jakob disease.² Annals Of Neurology. 47(5): 575-582. Wilson, D., R. Valluzzi, et al. (2000). ³Conformational transitions in model silk peptides.² Biophysical Journal. 78(5): 2690-2701. Wilson, K., C. Code, et al. (2000). ³Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies.² British Medical Journal. Jul 321(7252): 17-19. Winklhofer, K. F. and J. Tatzelt (2000). ³Cationic lipopolyamines induce degradation of PrPSc in scrapie-infected mouse neuroblastoma cells.² Biological Chemistry. Jun 381(5-6): 463-469. Wong, B. S., C. Clive, et al. (2000). ³Copper has differential effect on prion protein with polymorphism of position 129.² Biochemical And Biophysical Research Communications. 269(3): 726-731. Wong, B. S., T. Pan, et al. (2000). ³Differential contribution of superoxide dismutase activity by prion protein in vivo.² Biochemical And Biophysical Research Communications. Jun 273(1): 136-139. Wrathall, A. E. (2000). ³Risks of transmission of spongiform encephalopathies by reproductive technologies in domesticated ruminants.² Livestock Production Science. 62(3): 287-316. Yang, C. M. and Y. Chen (2000). ³"Protein-only" or "virino" in prion diseases?² Chinese Science Bulletin. 45(3): 285-288. Zagrodzki, P., H. Szmigiel, et al. (2000). ³The role of selenium in iodine metabolism in children with goiter.² Environmental Health Perspectives. 108(1): 67-71. Zbilut, J. P., C. L. Webber, et al. (2000). ³The role of hydrophobicity patterns in prion folding as revealed by recurrence quantification analysis of primary structure.² Protein Engineering. 13(2): 99-104. Zeidler, M., A. J. E. Green, et al. (2000). ³Case 28-1999: Creutzfeldt-Jakob disease.² New England Journal Of Medicine. 342(4): 292. Zeidler, M. and J. W. Ironside (2000). ³The new variant of Creutzfeldt-Jakob disease.² Revue Scientifique Et Technique De L Office International Des Epizooties. 19(1): 98-120. Zeidler, M., R. J. Sellar, et al. (2000). ³The pulvinar sign on magnetic resonance imaging in variant Creutzfetdt-Jakob disease.² Lancet . 355(9213): 1412-1418. Zeidler, M. (2000). ³14-3-3 cerebrospinal fluid protein and Creutzfeldt-Jakob disease.² Annals Of Neurology. 47(5): 683-684. Zeidler, M. (2000). ³The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease (vol 355, pg 1412, 2000).² Lancet . Jul 356(9224): 170. Zerr, I., J. P. Brandel, et al. (2000). ³European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors.² Journal Of Clinical Epidemiology. Jul 53(7): 747-754. Zhang, L., W. Q. Zhao, et al. (2000). ³TNF-alpha induced over-expression of GFAP is associated with MAPKs.² Neuroreport . 11(2): 409-412. Zhang, J. T., E. Han, et al. (2000). ³Role of the ribosome in sequence-specific regulation of membrane targeting and translocation of P-glycoprotein signal-anchor transmembrane segments.² Journal Of Cell Science. Jul 113(14): 2545-2555. Zinn, C. (2000). ³Nine hospital patients may have been exposed to CJD.² British Medical Journal. 320(7245): 1296. Zlotogora, J., G. Bach, et al. (2000). ³Molecular basis of mendelian disorders among Jews.² Molecular Genetics And Metabolism. 69(3): 169-180. Zulianello, L., K. Kaneko, et al. (2000). ³Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.² Journal Of Virology. 74(9): 4351-4360. | |
|
